Loading...
  • treatment
  • Daratumumab is a human CD38-directed monoclonal antibody indicated for the treatment of relapsed and refractory multiple myeloma (MM). (bioportfolio.com)
  • Trending serial CSF samples to guide treatment of refractory coccidioidal meningitis with intrathecal liposomal amphotericin. (bioportfolio.com)
  • cells
  • in AML, their functioning is disrupted and results in numerous non-functioning white cells, which can potentially interfere with the body's ability to control infections and can lead to anaemia and haemorrhages. (celgene.com)
  • combination
  • 4) IL-3, IL-6, IL-11, GM-CSF, M-CSF or EPO alone or in combination could increase the megakaryocyte colony formation in some children with aplastic anemia. (nii.ac.jp)
  • disease
  • MDS sub-types, as defined by the FAB-working group, have prognostic significance in the elderly, in whom survival and incidence of AML progression are more favorable in lower stages of the disease (lower blast cell count). (atlasgeneticsoncology.org)
  • risk
  • REVLIMID is also approved in the United States , Canada , Switzerland , Australia , New Zealand and several Latin American countries, as well as Malaysia and Israel , for transfusion-dependent anaemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. (celgene.com)